Ky. Lam et al., The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas, J CLIN PATH, 54(6), 2001, pp. 443-448
Citations number
20
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Aims-Phaeochromocytomas and paragangliomas are uncommon. The aims of this s
tudy were to analyse the characteristics and the possible roles of p53, Rb,
and mdm2 alterations in these tumours.
Methods-The clinicopathological features of 65 patients (31 men, 34 women)
with phaeochromocytomas or paragangliomas were analysed. The tumours were s
tudied for the expression of p53, Rb, and mdm2 by immunohistochemical metho
ds.
Results-Thirty nine of the patients had phaeochromocytomas and 26 had parag
angliomas. Bilateral tumours were noted in eight of the patients and malign
ant tumours were seen in 13. Paragangliomas were often small, non-functiona
l, and presented incidentally, whereas phaeochromocytomas were usually larg
e, functional, and symptomatic, p53 overexpression, loss of Rb expression,
and mdm2 overexpression were seen in four, 43, and 37 of the patients, resp
ectively. Three of the four patients with p53 overexpression had bilateral
tumours. Loss of Rb expression was often found in phaeochromocytomas, where
as mdm2 overexpression was more frequently seen in paragangliomas. The 10 y
ear survival rate of patients with malignant tumours was 45%. Two patients
died of tumour metastases more than 10 years after resection of the primary
tumours.
Conclusions-Phaeochromocytomas and paragangliomas had distinctive clinical
features and genetic alterations. The prognosis of patients with these tumo
urs was related to the malignant potential, p53 overexpression, more common
in bilateral phaeochromocytomas and paragangliomas, could be a marker for
this tumour subgroup.